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or Post op AF
(n=293)
(%) Mean + SD
Post op AF
(n=124)
(%) Mean + SD
P value
Age, years 67.8 + 12.5 72.4 + 9.9 <.01
Female 124 (42.9) 53 (42.7) .975
Smoker 43 (14.9) 11 (8.8) .097
History	of	heart	failure	 102 (35.3) 37 (29.8) .282
Left	ventricular	ejection	fraction 53.2 + 12.0 54.2 +  12.1 .410
Past Medical History
Hypertension 200 (69.2) 98 (79.0) .621
Diabetes	Mellitus 77 (26.6) 34 (27.4) .871
History	of	tobacco	use 158 (54.7) 73 (58.90 .431
COPD 68 (23.5) 29 (23.4) .975
Cerebrovascular	accident 22 (7.6) 8 (6.5) .677
Medications
Beta	blockers 126 (43.6) 60 (48.4) .370
ACE	inhibitors 103 (35.6) 39 (31.5) .411
ARB 47 (16.3) 20 (16.1) .973
Amiodarone 5 (1.7) 0 .328
Statins 156 (54.0) 72 (58.1) .444
Echocardiographic Findings
Left	ventricular	wall	thickness 1.35 + 0.31 1.38 + 032 .356
Left	atrial	diameter 4.53 + 1.0 4.6 + 0.8 .812
Surgical Details
Cardiopulmonary	bypass	duration 138.0 + 50.9 132.8 + 50.7 .555
Coronary	bypass	surgery	
performed 128 (45.4) 66 (53.2) .145
Mitral	valve	surgery 75 (26.0) 28 (22.6) .468
Aortic	valve	surgery 225 (77.9) 99 (79.8) .653
Comparison of Outcomes of the Three Groups
Patients with 
Neither Persistent 
or Post op AF
(n=293)
(%) Mean + SD
Post op AF
(n=124)
(%) Mean + SD
P value
Prolonged	ventilation 13 (4.5) 14 (11.3) .01
Heart	block 19 (6.6) 7 (5.6) .722
Sternal	wound	infection 1 (0.3) 0 1.0
Pneumonia 3 (1.0) 3 (2.4) .371
Septicemia 7 (2.4) 7 (5.6) .097
Stroke 9 (3.1) 10 (8.1) .028
In	hospital	mortality 11 (3.8) 3 (2.4) .568
Hospital	stay	duration,	days 7.12 + 4.9 11.3 + 8.3 <.01
•		Retrospective	clinical	and	statistical	analysis	was	conducted	on	556	
consecutive	patients	who	underwent	cardiac	valve	surgery	at	Lehigh	
Valley	Health	Network	during	2005-2007.		
•		139	with	persistent	AF	before	the	surgery	were	excluded.	
•		Statistical	analyses	included	chi-square	test	for	categorical	and	the	
student	t-test	for	continuous	variables.		
•	Multivariate	logistic	regression	was	also	performed.
•		417	patients	(240	males	and	177	females)	were	studied.	POAF	
occurred	in	124	(30%)	of	the	patients.	
•		Age	(72.4	±	9.9	yrs	vs.	67.8	±	12.5;	p	<0.001.	OR	per	year	of	age:	
1.029;	95%	CI,	1.008-1.052)	was	significantly	associated	with	
occurrence	of	AF.	
•		Patients	with	POAF	had	a	significantly	longer	hospital	stay	(9.5	+/-	5.4	
days	vs.	6.9	+/-	4.3	days,	p	=	0.001).		
•		Neither	ARBs	(OR:	.994;	95%CI,	.538-1.836,	p=.985)	nor	ACE	
inhibitors	(OR:	1.160,	95%CI,	.723-1.860,	p=.539)	reduced	the	
occurrence	of	POAF.			
•		On	comparison	between	the	two	groups	(ACE	inhibitors	vs	ARB),	the	
occurrence	of	POAF	was	similar	(27.9%	vs	31.1%;	p=0.646).
